When lyophilizing a challenging biologic drug product, use an integrated approach optimizing formulation and process parameters together.
- Your 7 Decisions To Make Before MES Configuration
- Complete Response Letters For CGTs Share This Common Theme
- Finding The Therapeutic Window: Using Single-Cell Biology To Build More Selective T-Cell Engagers
- DEA Reveals Hidden Costs Of Analytical Validation Guidelines
- What LSPA's Life Sciences Future Says About The Road Ahead For CGT
- FDA Modernizes Container Closure Guidance: What Is Changing And Why It Matters
- CDMO Selection Beyond Capabilities And Price
- August 2026 — CDMO Opportunities And Threats Report
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Characterizing AAV Payload With GMP-Compliant svAUC
Ensuring AAV quality starts with payload characterization. Learn why conventional methods may miss key capsid population insights.
-
Product Recovery Study For Fill Finish Applications
Surge bags are essential to fill finish efficiency, but poor drainage can cause costly product loss. Learn how drainage testing helps identify high-performance bags that maximize recovery and reduce waste.
-
Vial Adapter Transfer Device Compatibility With Cell Therapies
Needles and syringes are commonly used to retrieve cell therapies from vials, posing the risk of needle stick injury. Explore the suitability of needle-free polycarbonate transfer devices.
-
How To Effectively Manage Local Affiliate Pharmacovigilance Outsourcing
Managing PV across dozens of markets strains even experienced safety teams. Learn about a framework that helps you maintain compliance, reduce risk, and scale confidently into new markets.
-
Optimized Urine Liquid Biopsy Workflow
Urine-derived cell-free DNA is revolutionizing liquid biopsy research to offer a non-invasive, accessible tool for early disease detection, monitoring, and comprehensive diagnostics across oncology.
-
Scaling Success: A Blueprint For Flexible Biometrics Partnerships
Learn how a micro-FSP model and integrated biometrics team can scale from specialized support to a full-service solution, ensuring agility and consistency as clinical trial needs evolve.
-
Efficient Protein Purification Strategies
Examine two rapid, high‑throughput strategies for small‑scale protein separation, using either multimodal resins or ion exchange membranes to achieve efficient, low‑volume purification.
-
Flow Cytometric Analysis: Differentiation Potential Of Human Stem Cells
Explore an assay kit that simplifies handling with a methylcellulose-free medium and clear flow cytometric readout, which enhances automation and high-throughput sample acquisition for versatile research.
-
Enhancing mAb Production: Advanced Downstream Purification Strategies
Explore how process optimization can address downstream mAb manufacturing bottlenecks, reduce labor and consumable costs, and support more efficient production without compromising performance.
-
Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere
Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.
NEWSLETTER ARCHIVE
- 10.16.26 -- Manufacturing Solutions For Scalable Cell Therapy Production
- 10.16.26 -- Traversing Complexity In Breast Cancer Clinical Development
- 10.15.26 -- Your Vector Is Deciding The Path Of Your Cell & Gene Therapy Program
- 10.15.26 -- Which Viral Clearance Step Delivers The Highest LRV?
- 10.15.26 -- A Sponsor's Guide To Smarter Viral Vector CDMO Partnerships
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
- What LSPA's Life Sciences Future Says About The Road Ahead For CGT
- Inside Scaling Next-Gen MSCs Without Scaling Risk
- Inside Kyverna's Autoimmune CAR T Platform Beyond SPS
- Autoimmune CAR T Has Hit A Critical Moment. Are We Asking The Right Questions?
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections
